NASH Will Be Top of Mind at EASL, Nomura Says (ICPT)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/27/2026
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices slide about 2% as US, Iran explore path out of war
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- White House blocks CNN from Air Force One trip, Washington Post reports
- Merck and Daiichi Sankyo withdraw lung cancer drug application
- Exclusive-SK Hynix's Solidigm weighs IPO that could value the unit at up to $150 billion, sources say
- Fox Factory sells Marucci Sports for $225M, cuts debt
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
Wedbush Comments on Intercept Pharmaceuticals (ICPT) Ahead of Upcoming EASL Presentations
April 9, 2015 7:15 AM EDTWedbush analyst Liana Moussatos highlighted Intercept Pharmaceuticals (NASDAQ: ICPT) as the company is expected to present two late-breaking presentations at the European Association for the Study of the Liver (EASL, April 22-26, Vienna, Austria.
"These presentations are expected to highlight the benefits of OCA use... More
Intercept Pharma (ICPT) Added to Short Term Buy List at Deutsche Bank
April 8, 2015 7:10 AM EDTIntercept Pharma (NASDAQ: ICPT) Added to Short Term Buy List at Deutsche Bank
... More